These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10560899)

  • 1. A pharmacotherapy algorithm for the treatment of dysthymia in Japan.
    Kitamura H; Yokoyama T; Someya T
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S49-53. PubMed ID: 10560899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine use of operational diagnostic criteria affects the pharmacotherapy of dysthymia: national questionnaire survey of experienced psychiatrists in Japan.
    Endo T; Shioiri T; Kitamura H; Someya T
    Psychiatry Clin Neurosci; 2006 Aug; 60(4):521-3. PubMed ID: 16884457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials.
    Levkovitz Y; Tedeschini E; Papakostas GI
    J Clin Psychiatry; 2011 Apr; 72(4):509-14. PubMed ID: 21527126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant use in nonmajor depression: secondary analysis of a program to encourage active, rewarding lives for seniors (PEARLS), a randomized controlled trial in older adults from 2000 to 2003.
    Lakey SL; Gray SL; Ciechanowski P; Schwartz S; Logerfo J
    Am J Geriatr Pharmacother; 2008 Mar; 6(1):12-20. PubMed ID: 18396244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.
    Barrett JE; Williams JW; Oxman TE; Frank E; Katon W; Sullivan M; Hegel MT; Cornell JE; Sengupta AS
    J Fam Pract; 2001 May; 50(5):405-12. PubMed ID: 11350703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antidepressants consumption in the global population in France].
    Olié JP; Elomari F; Spadone C; Lépine JP
    Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of dysthymia].
    Pöldinger W
    Praxis (Bern 1994); 2000 Dec; 89(51-52):2183-8. PubMed ID: 11197300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long-term outcome of dysthymia in private practice: clinical features, temperament, and the art of management.
    Haykal RF; Akiskal HS
    J Clin Psychiatry; 1999 Aug; 60(8):508-18. PubMed ID: 10485632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithms for the pharmacotherapy of major depression.
    Shioe K; Kanba S
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S77-82. PubMed ID: 10560904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An open-label pilot study to evaluate the efficacy of sildenafil citrate in middle-aged men with late-onset dysthymia.
    Orr G; Seidman SN; Weiser M; Gershon AA; Dubrov Y; Klein DF
    J Nerv Ment Dis; 2008 Jun; 196(6):496-500. PubMed ID: 18552628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of drug treatments for dysthymia: a systematic review and meta-analysis.
    de Lima MS; Hotoph M; Wessely S
    Psychol Med; 1999 Nov; 29(6):1273-89. PubMed ID: 10616934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dysthymia: a chronic illness and its treatment].
    Aschauer HN
    Wien Med Wochenschr; 1999; 149(18):503-10. PubMed ID: 10637954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicide rates in short-term randomized controlled trials of newer antidepressants.
    Hammad TA; Laughren TP; Racoosin JA
    J Clin Psychopharmacol; 2006 Apr; 26(2):203-7. PubMed ID: 16633153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic deficit and the role of amisulpride in the treatment of mood disorders.
    Montgomery SA
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S9-15; discussion S16-7. PubMed ID: 12685917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression.
    Bauer M; Pfennig A; Linden M; Smolka MN; Neu P; Adli M
    J Clin Psychopharmacol; 2009 Aug; 29(4):327-33. PubMed ID: 19593170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence.
    De Lima MS; Hotopf M
    Drug Saf; 2003; 26(1):55-64. PubMed ID: 12495364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geriatric dysthymia.
    Kocsis JH
    J Clin Psychiatry; 1998; 59 Suppl 10():13-5. PubMed ID: 9720477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for switching antidepressants to achieve maximum efficacy adolescents.
    Jefferson JW
    J Clin Psychiatry; 2008; 69 Suppl E1():14-8. PubMed ID: 18494539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of testosterone replacement in middle-aged men with dysthymia: a randomized, placebo-controlled clinical trial.
    Seidman SN; Orr G; Raviv G; Levi R; Roose SP; Kravitz E; Amiaz R; Weiser M
    J Clin Psychopharmacol; 2009 Jun; 29(3):216-21. PubMed ID: 19440073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidepressant efficacy in the treatment of dysthymia.
    Invernizzi G; Mauri MC; Waintraub L
    Eur Neuropsychopharmacol; 1997 Oct; 7 Suppl 3():S329-36. PubMed ID: 9405959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.